DIMENSION? CLINICAL CHEMISTRY XYSTEM DF93A

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2015-07-15 for DIMENSION? CLINICAL CHEMISTRY XYSTEM DF93A manufactured by Siemens Healthcare Diagnostics Inc - Glasgow.

Event Text Entries

[22399649] Siemens healthcare diagnostics has determined that dimension urine opiate screen operated according to specification; siemens is filing this only to report a patient death at a subsequent treatment facility. The urine opiate screen detects morphine. Although heroin is metabolized to morphine, the concentration of morphine in urine may not be above the cut-off concentration (300 ng/ml) of the assay. As stated in the intended use of the dimension flex reagent cartridge urine opiates screen instructions for use: "opiates are absorbed rapidly. Heroin is converted almost immediately to morphine, which is excreted in urine both unchanged and as a glucuronidated metabolite. Excretion takes place over a period of a couple of days. " naloxone was administered in the ambulance which indicates that they were following standard procedure for a heroin overdose; ongoing management of the patient would require titration of naloxone as needed to maintain breathing and consciousness. Additionally, the dimension urine opiates screen states in the instructions for use: "the opi method provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas chromatography/mass spectrometry (gc/ms) is the preferred confirmatory method. Other chemical confirmation methods are available. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are used. " diluting a urine sample and running the sample and multiplying by the dilution factor is non-standard use when the urine opiate screen is run in qualitative mode. Per the instructions for use, the dilution can only be used in the semi-quantitative mode.
Patient Sequence No: 1, Text Type: N, H10


[22399650] A patient was brought to the (b)(6) hospital facility by ambulance with a diagnosis of heroin overdose. The patient had been treated with naloxone by the paramedics. The patient was in cardiac arrest. While at the hospital, the patient's urine tested negative for opiates with the dimension urine opiates screen. The er transferred the patient to another hospital where he died. There was no indication that patient treatment would have been altered or prescribed on the basis of the negative opiates result. There was no indication that a medical procedure or a medical treatment was delayed on the basis of the negative opiates result. There is no allegation that harm to the patient or the death was due to the negative opiate result.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2517506-2015-00159
MDR Report Key4917271
Date Received2015-07-15
Date of Report2015-06-30
Date of Event2015-06-29
Date Mfgr Received2015-06-30
Device Manufacturer Date2015-02-05
Date Added to Maude2015-07-15
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag0
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactEDWARD SZYMANSKI
Manufacturer StreetGLASGOW BUSINESS COMMUNITY PO BOX 6101
Manufacturer CityNEWARK DE 197146101
Manufacturer CountryUS
Manufacturer Postal197146101
Manufacturer Phone3026317672
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW
Manufacturer StreetGLASGOW BUSINESS COMMUNITY 500 GBC DRIVE
Manufacturer CityNEWARK DE 19714
Manufacturer CountryUS
Manufacturer Postal Code19714
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameDIMENSION? CLINICAL CHEMISTRY XYSTEM
Generic NameURINE OPIATES SCREEN FLEX? REAGENT CARTRIDGE
Product CodeDJG
Date Received2015-07-15
Catalog NumberDF93A
Device Expiration Date2016-02-05
OperatorMEDICAL TECHNOLOGIST
Device AvailabilityN
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS INC - GLASGOW
Manufacturer AddressGLASGOW BUSINESS COMMUNITY 500 GBC DRIVE NEWARK DE 19714 US 19714


Patients

Patient NumberTreatmentOutcomeDate
10 2015-07-15

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.